Dunedin manufacturer to launch probiotic in Asia

Last updated 05:00 24/08/2014

Relevant offers

Small Business

Papakura Configure Express members claim refund demands going unanswered Nelson bar named best Guinness pub in South Island Queenstown boutique Goddess closes as rent rises push small businesses out Government paper on retail payment systems out for public consultation Cafes baking up good results in people's choice cafe awards Google is taking on Skyscanner, Scotland's hottest startup New Hawke's Bay brewery to start producing 100,000 litres of beer a year Wellington restaurant Duke Carvell's can't pay $473,486 owed to creditors The food wrap saving the bees and the environment Designer Marlborough sleeping bags brighten nights for sick children

Dunedin-based oral health probiotic manufacturer Blis Technologies is about to launch a co-branded product with the Nekta Group into Asia.

Nekta Group and Asia Pacific Partners Ltd owner Adriana Tong was one of a group of trade partners and existing shareholders who put in a net $4.28 million late last year to stabilise Blis' finances.

The major shareholders now include Forsyth Barr chairman Eion Edgar, Dunedin investor and Blis director Tony Offen, Asia Pacific Partners, Christchurch-based NZPR Group and David Wu.

The company delivered its 13th loss in a row in May this year - although the $1.54m after-tax loss was lower than the previous year's record $1.85m loss. The new funds are expected to see the company through until it hits its forecast profitability next year.

Tong said they were combining Blis' oral probiotic with Nekta's kiwifruit-based beverages under the brand name Nekta Blis, and a distribution deal was close to being signed in Singapore.

Blis chief executive Dr Barry Richardson said the company had gained Registered Manufacturing Plant status earlier this month for its nutritional formulations plant in Dunedin following a delay in getting full export accreditation.

The delay was due to additional audit requirements imposed to ensure export access to China. Blis listed in 2001 but has chewed through millions in shareholders funds while only making disappointing progress in commercialisation of its probiotic products.

These include Blis K12 lozenges sold in New Zealand supermarkets which prevent bad breath, sore throats, and respiratory infections.

Richardson said China's largest pharmaceutical company Sinopharm has said it will distribute Blis products in 600 stores in the next few weeks following a successful trial in three stores.

Ad Feedback

- Sunday Star Times


Special offers
Opinion poll

Do you feel better off than at this time last year?



In some areas yes, others no

Vote Result

Featured Promotions

Sponsored Content